Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection. Read more about Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes. Read more about Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes.
A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding. Read more about A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding.
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area. Read more about SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area.
Test performance evaluation of SARS-CoV-2 serological assays. Read more about Test performance evaluation of SARS-CoV-2 serological assays.
